Author:
Tran W T,Iradji S,Sofroni E,Giles A,Eddy D,Czarnota G J
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Blakey DC, Westwood R, Walker M, Hughes GD, Davis PD, Ashton SE, Ryan AJ (2002) Antitumour activity of the novel vascular targeting agent ZD6126 in a panel of tumour models. Clin Cancer Res 8: 1974–1983
2. Cooney MM, van Heekcheren W, Bhakta S, Ortz J, Remick SC (2006) Drug insight: vascular disrupting agents and angiogenesis-novel approaches for drug delivery. Nature Clin Prac Oncol 12: 682–692
3. Dings RP, Loren M, Heun H, McNiel E, Griffioen AW, Mayo KH, Griffin RJ (2007) Scheduling of radiation with angiogenesis inhibitors anginex and avastin improves therapeutic outcome via vessel normalization. Clin Cancer Res 13 (11): 3395–3402
4. Duda DG, Batchelor TT, Willett CG, Jain RK (2007) VEGF-targeted cancer therapy strategies: current progress, hurdles and future prospects. Trends Mol Med 13 (6): 223–230
5. Feron O (2004) Targeting the tumour vascular compartment to improve conventional cancer therapy. Trends Pharmacol Sci 25 (10): 536–542
Cited by
57 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献